- Home
- TSHA vs TDOC Comparison
TSHA vs TDOC Comparison
Compare TSHA & TDOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TSHA | TDOC |
|---|---|---|
| Founded | 2019 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 841.2M |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TSHA | TDOC |
|---|---|---|
| Price | $4.46 | $5.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 17 |
| Target Price | ★ $10.56 | $7.63 |
| AVG Volume (30 Days) | 2.1M | ★ 5.8M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.50 | ★ 80.58 |
| EPS | ★ N/A | N/A |
| Revenue | $8,333,000.00 | ★ $2,406,840,000.00 |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | N/A | $1.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 18.41 |
| 52 Week Low | $1.13 | $4.40 |
| 52 Week High | $6.02 | $9.77 |
Technical Indicators
Market Signals| Indicator | TSHA | TDOC |
|---|---|---|
| Relative Strength Index (RSI) | 42.92 | 54.82 |
| Support Level | $4.41 | $4.44 |
| Resistance Level | $5.16 | $5.49 |
| Average True Range (ATR) | 0.20 | 0.26 |
| MACD | -0.00 | 0.14 |
| Stochastic Oscillator | 20.13 | 78.97 |
Price Performance
Historical ComparisonAbout TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About TDOC Teladoc Health Inc.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.